Mobilisation and vasoactive infusions: An observational study of practice across critical care

This prospective, single centre observational study will be undertaken for all patients admitted to the ICU and Acute Coronary Care Unit (ACCU) at Canberra Hospital over a three-month period requiring vasoactive and/or inotropic infusions (noradrenalin, adrenalin, dobutamine, vasopressin, milrinone, metaraminol, levasemendin, isoprenaline). This study will measure: -mobility rates -dosage of drug administer prior, during and post mobilisation -level of mobilisation utilising ICU mobility scale -attachments and sedation medication dosages during mobilisation -SOFA score on day of mobilisation and 24 hours post -mobility rates -adverse events during mobilisation and 24 hours post -functional outcome at ICU discharge (Acute Care Index of Function). Observation measures will be taken for the highest level of mobility that day on infusions. Mobility will be defined as any attempt at out of bed mobility (sitting on the edge of the bed, standing, transferring, ambulating, passively transferred to chair). We propose an observational study as mobilisation of patients on vasoactive and inotropic agents is already considered routine practice by physiotherapists and nursing staff in these areas.